Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Medical Buys Company to Add ECLIA Testing Products

publication date: Nov 26, 2007

China Medical will spend $28.8 million to acquire Beijing Bio-Ekon Biotechnology Co. Ltd., which develops and sells advanced in-vitro diagnostic (IVD) products. China Medical did not disclose revenue/profit figures for Beijing Bio-Ekon, but the company did say the acquisition would be accretive from the quarter ending March 31, 2008. In 2006, BBE launched the product that seems to be China Med’s chief reason for the acquisition: a semi-automatic ECLIA analyzer and related reagents. China Med is also heavily involved in the ECLIA business. More details..

Stock Symbol: (NSDQ: CMED)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital